Menarini Group and Insilico Medicine Announce Global License Agreement for Novel KAT6 Inhibitors

Retrieved on: 2024-01-05 17:43:31

Tags for this article:

Click the tags to see associated articles and topics

Menarini Group and Insilico Medicine Announce Global License Agreement for Novel KAT6 Inhibitors. View article details on hiswai:

Excerpt

Menarini Group and Insilico Medicine Announce Global License Agreement for Novel KAT6 Inhibitors. AdminJanuary 5, 2024. 47. 2024-01-05 11:58:00. KAT6 ...

Article found on: sparkchronicles.com

View Original Article